We are live on ! Find out more
ONCS

OncoSec Medical Incorporated

Delisted

ONCS was delisted on the 23rd of June, 2023.

33 hedge funds and large institutions have $2.64M invested in OncoSec Medical Incorporated in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

3% more funds holding

Funds holding: 3233 (+1)

75% less capital invested

Capital invested by funds: $10.4M → $2.64M (-$7.73M)

Holders
33
Holders Change
+1
Holders Change %
+3.13%
% of All Funds
0.74%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
10
Reduced
8
Closed
7
Calls
Puts
Net Calls
Net Calls Change

ONCS Hedge Fund Activity: Q4 2018 in Review

33 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2018, worth a combined $2.64M — down 75% from $10.4M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new ONCS positions and 7 closed out — a net gain of 1 holder — while 10 added to existing stakes and 8 trimmed.

The largest buyer was Anson Funds Management, opening a new position worth an estimated $735K. The largest seller was Nexthera Capital, exiting entirely with an estimated $1.94M sold.

  • 33 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2018, up from 32 in Q3 2018.
  • Funds reported $2.64M of OncoSec Medical Incorporated stock for Q4 2018, down 75% quarter-over-quarter.
  • 8 funds opened new OncoSec Medical Incorporated positions in Q4 2018 and 7 closed out, a net change of +1 holder.
  • The largest OncoSec Medical Incorporated buyer in Q4 2018 was Anson Funds Management, an estimated $735K added.
  • The largest OncoSec Medical Incorporated seller in Q4 2018 was Nexthera Capital, an estimated $1.94M sold.

Based on aggregated 13F filings for Q4 2018.